152 related articles for article (PubMed ID: 34435325)
1. The Clinical Significance and Functional Role of miR-466 in Gastric Cancer Peritoneal Metastasis.
Wang Y; Yan B; Ni L; Si Y; Cao P
Mol Biotechnol; 2022 Jan; 64(1):25-32. PubMed ID: 34435325
[TBL] [Abstract][Full Text] [Related]
2. MiR-136 inhibits gastric cancer-specific peritoneal metastasis by targeting HOXC10.
Zheng J; Ge P; Liu X; Wei J; Wu G; Li X
Tumour Biol; 2017 Jun; 39(6):1010428317706207. PubMed ID: 28656883
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of miR-484 is associated with poor prognosis and tumor progression of gastric cancer.
Li Y; Liu Y; Yao J; Li R; Fan X
Diagn Pathol; 2020 Mar; 15(1):25. PubMed ID: 32192507
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance.
Hashiguchi Y; Nishida N; Mimori K; Sudo T; Tanaka F; Shibata K; Ishii H; Mochizuki H; Hase K; Doki Y; Mori M
Int J Oncol; 2012 May; 40(5):1477-82. PubMed ID: 22322911
[TBL] [Abstract][Full Text] [Related]
5. miR-3196 acts as a Tumor Suppressor and Predicts Survival Outcomes in Patients With Gastric Cancer.
Chen G; Wan J; Wang Z; Li L; Jia H; Xing S; Chen S; Fan X; Li R
Technol Cancer Res Treat; 2020; 19():1533033820923427. PubMed ID: 32419651
[TBL] [Abstract][Full Text] [Related]
6. Downregulation miR-539 is associated with poor prognosis of gastric cancer patients and aggressive progression of gastric cancer cells.
Jin W; Han H; Liu D
Cancer Biomark; 2019; 26(2):183-191. PubMed ID: 31403943
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of miR-892a in gastric cancer and its regulatory effect on tumor progression.
Lv J; Zhang H; Gao Z; Zhang X; Huang X; Jia X
Cancer Biomark; 2020; 28(2):247-254. PubMed ID: 32390603
[TBL] [Abstract][Full Text] [Related]
8. Exosomal miRNAs from Peritoneum Lavage Fluid as Potential Prognostic Biomarkers of Peritoneal Metastasis in Gastric Cancer.
Tokuhisa M; Ichikawa Y; Kosaka N; Ochiya T; Yashiro M; Hirakawa K; Kosaka T; Makino H; Akiyama H; Kunisaki C; Endo I
PLoS One; 2015; 10(7):e0130472. PubMed ID: 26208314
[TBL] [Abstract][Full Text] [Related]
9. Exosomal miR-21-5p derived from gastric cancer promotes peritoneal metastasis via mesothelial-to-mesenchymal transition.
Li Q; Li B; Li Q; Wei S; He Z; Huang X; Wang L; Xia Y; Xu Z; Li Z; Wang W; Yang L; Zhang D; Xu Z
Cell Death Dis; 2018 Aug; 9(9):854. PubMed ID: 30154401
[TBL] [Abstract][Full Text] [Related]
10. microRNA-203 suppresses invasion of gastric cancer cells by targeting ERK1/2/Slug/ E-cadherin signaling.
Gao P; Wang S; Jing F; Zhan J; Wang Y
Cancer Biomark; 2017; 19(1):11-20. PubMed ID: 28269747
[TBL] [Abstract][Full Text] [Related]
11. miR-130a acts as a potential diagnostic biomarker and promotes gastric cancer migration, invasion and proliferation by targeting RUNX3.
Jiang H; Yu WW; Wang LL; Peng Y
Oncol Rep; 2015 Sep; 34(3):1153-61. PubMed ID: 26134263
[TBL] [Abstract][Full Text] [Related]
12. Extracellular vesicle derived miR-544 downregulates expression of tumor suppressor promyelocytic leukemia zinc finger resulting in increased peritoneal metastasis in gastric cancer.
Kong W; Liu X; Yin G; Zheng S; Zhu A; Yu P; Shan Y; Ying R; Zhang J
Aging (Albany NY); 2020 Nov; 12(23):24009-24022. PubMed ID: 33221764
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic modulation and repression of miR-200b by cancer-associated fibroblasts contribute to cancer invasion and peritoneal dissemination in gastric cancer.
Kurashige J; Mima K; Sawada G; Takahashi Y; Eguchi H; Sugimachi K; Mori M; Yanagihara K; Yashiro M; Hirakawa K; Baba H; Mimori K
Carcinogenesis; 2015 Jan; 36(1):133-41. PubMed ID: 25411357
[TBL] [Abstract][Full Text] [Related]
14. MiR-652 serves as a prognostic biomarker in gastric cancer and promotes tumor proliferation, migration, and invasion via targeting RORA.
Li J; Zou X
Cancer Biomark; 2019; 26(3):323-331. PubMed ID: 31524147
[TBL] [Abstract][Full Text] [Related]
15. MiRNA-3978 regulates peritoneal gastric cancer metastasis by targeting legumain.
Zhang Y; Wu YY; Jiang JN; Liu XS; Ji FJ; Fang XD
Oncotarget; 2016 Dec; 7(50):83223-83230. PubMed ID: 27793040
[TBL] [Abstract][Full Text] [Related]
16. LncRNA ASMTL-AS1/microRNA-1270 differentiate prognostic groups in gastric cancer and influence cell proliferation, migration and invasion.
Song Z; Wang J
Bioengineered; 2022 Jan; 13(1):1507-1517. PubMed ID: 34986743
[TBL] [Abstract][Full Text] [Related]
17. Metastasis-associated long non-coding RNA drives gastric cancer development and promotes peritoneal metastasis.
Okugawa Y; Toiyama Y; Hur K; Toden S; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Kusunoki M; Boland CR; Goel A
Carcinogenesis; 2014 Dec; 35(12):2731-9. PubMed ID: 25280565
[TBL] [Abstract][Full Text] [Related]
18. MiR-30a suppresses metastasis of gastric adenocarcinoma via targeting FAPα.
Yu T; Gong L; Li W; Zuo Q; Cai D; Mao H; Wang L; Lin J; Xiao B
Cancer Biomark; 2020; 27(4):471-484. PubMed ID: 32116236
[TBL] [Abstract][Full Text] [Related]
19. Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer.
Imaoka H; Toiyama Y; Okigami M; Yasuda H; Saigusa S; Ohi M; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
Gastric Cancer; 2016 Jul; 19(3):744-53. PubMed ID: 26233325
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of miR-552 Predicts Unfavorable Prognosis of Gastric Cancer and Promotes the Proliferation, Migration, and Invasion of Gastric Cancer Cells.
Feng X; Zhu M; Liao B; Tian T; Li M; Wang Z; Chen G
Oncol Res Treat; 2020; 43(3):103-111. PubMed ID: 31958799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
